MEDIA

Why India struggles to keep its food safe (Deccan Herald, May 13, 2024)
Govt defends omission of rule restricting Ayurveda drug ads (Hindustan Times, May 7, 2024)
The absence of a quality mindset (Business Standard, May 7, 2024)
China can win without firing a single shot (Navbharat Times, May 6, 2024)
Every Vaccine carries a risk. If the benefits outweight it, you use it: Shahid Jameel (Economic Times, May 5, 2024)
Report on rare adverse side effects of Covidshield causes panic. But should it? (The Wire, May 5, 2024)
Major Indian drug makers Cipla, Glenmark, recall products from the US market over manufacturing lapses (The North Lines, May 5, 2024)
Why implementing drug regulation policies are still a challenge in India (The Week, May 5, 2024)
Unscientific Temper (The Telegraph, May 4, 2024)
Covidshield under scanner. Is Covaxin safe? (Times of India, May 3, 2024)
Panel to reform drug pricing authority packed with industry representatives (Times of India, May 3, 2024)
Covidshield's rare side effects: In election season, dangers of politicizing vaccine (Indian Express, May 2, 2024)
Decades late, these set of basic rules for Indian Pharma can save lives (Economic Times, May 1, 2024)
477 Pune pharmaceutical stores found operational without pharmacists after FDA inspection (Pune Pulse, April 30, 2024)
Record US drug shortage a positive for Indian Pharma companies (Business Today, April 30, 2024)
Drug firms told to set up system for prompt recalls (Economic Times, April 30, 2024)
Indian state suspends licenses of 14 product of yoga guru in latest setback (Reuters, April 29, 2024)
Patanjali Saga: Ayush Ministry issues warning on misleading ads to traditional drugmakers (Business Today, April 27, 2024)
20 Drugs made in HP pharma firms failed testing in March (Times of India, April 27, 2024)
Panel to finalize list of over-the-counter drugs for sale at general stores (Economic Times, April 22, 2024)
US FDA pulls Natco Pharma for several violations at their Telangana plant (Business Standard, April 21, 2024)
Regulator issues distribution guidelines to ensure no substandard pharma products in market (The Print, April 18, 2024)
FDA slams three Indian drug makers in a flurry of recent form 483s (Fierce Pharma, April 16, 2024)
FDA lambasts Kilitch for unsanitary manufacturing conditions and issues warning letter to Natco (Fierce Pharma, April 10, 2024)
Cartelization of pharma trade bodies (The Hindu, April 10, 2024)
Drug recall still voluntary, experts express concern (Hindustan Times, April 8, 2024)
What if you consumed expired medicines, just a month late (India Today, April 8, 2024)
Dangerous game:On Patanjali's Ayurved claims (The Hindu, April 4, 2024)
Himachal Pradesh probes 1680 failed drug samples in Baddi (Hindu Business Line, March 29, 2024)
India pharma quality lapses force US to look to China for lifesaving drugs (Nikkei Asia, March 22,2024)
Seven firms that failed drug quality tests gave money to political parties through electoral bonds (Scroll.in, March 18, 2024)
Fake Cancer drug case: 4 more employees of Delhi, Gurgaon hospitals arrested (Indian Express, March 16, 2024)
7 arrested for manufacture, sale of "life-saving" cancer drugs in Delhi: Here's how the gang operated (Indian Express, March 13, 2024)
Why India needs a regulatory pathway for biosimilars? (Scroll.in, March 7, 2024)
33 drug samples of 21 Pharma Companies in Rajasthan fail testing (Zee Rajasthan, March 6, 2024)
Uzbekistan: Deadly cough syrup trial ends with lengthy convictions (Eurasianet, February 27,2024)
Several small pharma units told to halt operations over quality (Economic Times, February 23, 2024)
Licenses of 64 pharma companies canceled after government crackdown (The Hindu, February 19, 2024)
Drug regulator tightens sampling norms to test quality of medicines (The Print, February 17, 2024)
NHRC issues notice to Health Ministry, DCGI over drugs' brand name issue: seeks response in 4 weeks (Deccan Herald, February 12, 2024)
Rx Dose of Quality Control Meds (The Economic Times, February 10, 2024)
India's problem: different drugs, identical brand names (The Hindu, January 25, 2024)
"The response defies belief": Year of inaction leaves children at risk from bad cancer drugs (STATNews, January 25, 2024)
Nigeria tightens rules on Indian pharma exports, new standards may spark industry concerns (News18.com, January 17, 2024)
AAP government procured drugs from two blacklisted pharma firms with many failed quality tests (Newslaundry, January 17, 2024)
The story of a drug that India has failed to ban (Scroll.in, January 3, 2024)
Uttarakhand drug regulator enforces ban on cough syrup production without testing for toxic chemicals (News18.com, December 26, 2023)
India probe into bribery claim in toxic syrup tests nears completion (Reuters, December 21, 2023)
How tainted chemo wound up in Pediatric Cancer wards (Bloomberg Businessweek, December 15, 2023)
The threat of tainted cancer drugs (Bloomberg Businessweek, December 15, 2023)
CDSCO uncovers data manipulation, SOP violations by public testing labs (Economic Times, December 15, 2023)
India's medicine regulator is criticized for quality checking only cough medicines destined for export (BMJ, December 14, 2023)
Union chemicals and fertilizer ministry says 303 of 504 central drug inspector posts vacant (The Telegraph, December 10, 2023)
India's alarming "fixed dose combination" problem (The Hindu, December 8, 2023)
Complaint to PMO on medicine ads: Doctor cries inaction on misleading claims (The Telegraph, December 8, 2023)
The business of bad medicine (Bloomberg, December 5, 2023)
Over 50 cough syrup makers fail quality tests (Economic Times, December 3, 2023)
Pill Pain: India's weak, convoluted and inefficient regulatory structure for FDCs (The Telegraph, December 1, 2023)
65% of MSME firms found manufacturing substandard drugs since Dec (Business Standard, November 30, 2023)
Getting pharma regulation right should be top priority (The Tribune, November 29, 2023)
Indian drug manufacturers benefit from Big Pharma interest beyond China (Reuters, November 26, 2023)
China-made Gelatin in Indian Medicines sparks regulatory clampdown on poor quality material (News18, November 25, 2023)
Modi Govt plans to use videography, Latest Digital solutions during raids at pharma firms (News18, November 25, 2023)
Drug regulator halts production at 76 units over poor standards (Economic Times, November 23, 2023)
India wide inspections of Pharma firms exposed major lapses in drug manufacturing, shows Govt analysis (News18.com, November 23, 2023)
Gambia parents 'fight for children' in landmark trial on India syrup deaths (Al Jazeera, November 20, 2023)
India must save the reputation of its Pharma industry (Business Standard, November 16, 2023)
Tainted Walmart, CVS eyedrops tied to unsanitary Indian factory (Bloomberg, November 10, 2023)
Shortcast of Coffee Podcast (November 8, 2023)
Boss of Indonesia cough syrup maker jailed after child deaths (BBC, November 2, 2023)
Two labs in India take on bulk testing for cough syrup samples for export (The Hindu, October 17, 2023)
Pharmacy: Heal Thyself - Kasauli Literature Fest (YouTube, October 14, 2023)
UP Govt allows cough syrup company linked to Uzbek deaths to re-open factory (Business Today, October 11, 2023)
Silencing of the LiverDoc and the dangerous anti-science trend in India today (Indian Express, October 10, 2023)
Improving drug procurement through a contract life-cycle approach (XDR, October 10, 2023)
Drug contamination crisis:Indian Pharma industry faces regulatory crackdown (CNBC TV18, October 9, 2023)
RSS's pharma body writes to Health Ministry criticizing risk based inspections, backtracks later (News18, July 18, 2023)
Inspections resembling raids: RSS affiliate urges Govt to avoid "minor lapses" in Pharma firms (The Wire, October 7, 2023)
Diabeties drug among 48 to fail quality test (The Mint, October 5, 2023)
From Flawed data entries to no pest control and more: Inside details of probe into Kala-Amb based pharma firm (News18, October 5, 2023)
India declares two syrups from Norris Medicines as toxic after reports of poisoning deaths (WION, October 5, 2023)
India finds two more toxic cough syrups months after poisoning deaths (Reuters, October 4, 2023)
India manufactured syrups for cough, allergic rhinitis contamined with toxic levels of chemicals: CDSCO (Indian Express, October 4, 2023)
No unnecessary roaming - CDSCO is a sensitive office: Regulates visitors' entry with immediate effect (News18, September 30, 2023)
Cough syrup killed scores of children. Why no one has been held to account (Reuters, September 14, 2023)
Equal access to safe medicines is a Global Human Right (NY Times, September 11, 2023)
The curious case of a "killer" drug with contradictory toxin test results at different government labs (The Wire, September 9, 2023)
How can we maintain the success of existing anti-microbials? (Chemistry World, September 4, 2023)
Jammu: Long wait for justice after India cough syrup deaths (BBC, September 3, 2023)
I accept inferior drugs were bought to Lanka (The Sunday Times, September 3, 2023)
Patient safety or affordability: What should India prioritize? (Deccan Herald, September 2, 2023)
Drug regulator to closely monitor small drug firms (The Mint, September 1, 2023)
Whatever happened to the case of 66 child deaths linked to cough syrups from India ? (NPR, August 31, 2023)
Decoded:How India makes affordable drugs for the developed world, but deadly medicines for developing countries (Economic Times, August 31, 2023)
Carry on, Doctor (The New Indian Express, August 27, 2023)
Doctors in India raise concerns about new mandate to prescribe generic drugs (BMJ, August 22, 2023)
Maiden Pharmaceuticals:Fury in The Gambia over India cough syrup deaths (BBC, August 21, 2023)
Why India isnt ready for Generic Prescriptions yet (Manorama, August 20, 2023)
Jan Vishwas Bill: Harms common people, profits for the industry? (Lallantop, August 19, 2023)
Affordability is tied to quality (Express Pharma, August 18, 2023)
NDTV Jan Vishwas Act Debate: Viewers should know if panelists have a conflict of interest (Newslaundry, August 17, 2023)
Uzbekistan says contaminated Indian cough syrup was on the market due to bribery (Reuters, Aug 16, 2023)
Hum Log: Why has the WHO issued alert for a product made by Indian pharma company (NDTV India, August 15, 2023)
Why doctors are protesting rule to prescribe generic drugs (Indian Express, August 15, 2023)
A dose of danger: Spurious supplements harm consumers (Deccan Herald, August 15, 2023)
If Govt action was enough, why is the WHO still flagging India made medicines? Asks Expert (NDTV, August 13, 2023)
Jan Vishwas Bill and its impact on healthcare (Herald Goa, August 11, 2023)
Enforcement of drug regulations is Lax (The Tribune, August 10, 2023)
To protect its image in pharmacy world, India should shut firms who dont comply (News18.com, August 7, 2023)
World's largest abortion pill maker has a dark India link it might not be able to shake (Economic Tines, August 4, 2023)
Jan Vishwas Bill: A prescription for disaster (National Herald, August 4, 2023)
Industry, patient groups want draft drugs and medical devices bill recalled (Business Standard, August 4, 2023)
Freedom from Jail in 180 crimes, Jan Vishwas Bill changes laws (Jhakas Khabar, August 4, 2023)
India finds "violations" at a cough syrup maker linked to deaths in Cameroon (Reuters, August 4, 2023)
Jan Vishwas Bill: Will manufacturers of substandard drugs get away with just a fine? (Indian Express, August 4, 2023)
Why does India have a substandard drug problem ? (The Hindu Podcast, August 3, 2023)
Bill to ease penalties for low quality drugs passed in the parliament (Hindustan Times, August 3, 2023)
Jan Vishwas Bill, passed recently, further weakens regulation of pharmacies, experts say (Newsclick, August 3, 2023)
The Jan Vishwas Bill passed by Lok Sabha further dilutes regulation of pharmacies (Scroll.in, August 2, 2023)
Jan Vishwas Bill passed by Rajya Sabha, experts raise red flag (CNBC TV18, August 2, 2023)
India finds string of deficiencies among drug makers after risk tests (ET Health, August 2, 2023)
Global abortion pill provider buys from manufacturer with shoddy quality record (Bloomberg, August 1, 2023)
Modi's Jan Vishwas Bill gives the pharmaceutical industry a get-out-of-jail card (Newlaundry, August 1,2023)
Jan Vishwas Bill- All you need to know ( News 9, August 1, 2o23)
Jan Vishwas Bill: No Jail term, only fines for drugs manufactured in violation of norms (CNBC-TV18, August 1, 2023)
Editorial: Short of expectations (Telangana Today, July 31, 2023)
A critical lapse in Jan Vishwas Bill (Business Standard, July 31, 2023)
Generic 2: Calls for Regulatory Vigilance (Business Standard, July 31, 2023)
My take - Dinesh Thakur: Deal between Govt and industry puts patients at risk (The Public India, July 30, 2023)
Jan Vishwas Bill: Changes to Drugs and Cosmetics Act trigger debate over punishment for substandard medicines (Indian Express, July 29, 2023)
"Weakened" Drugs and Cosmetics Act raises alarm among health experts (The New Indian Express, July 29, 2023)
Medicine convicts can stay out of jail by paying fine, says Union Health Ministry (The Telegraph, July 29. 2023)
Jan Vishwas Bill passed amid ruckus on Manipur: Threat to lives for ease of doing business (The Public India, July 29, 2023)
Questions raised about quality of cough syrup, why are rules not enforced? (NDTV, July 28, 2023)
How does the Jan Vishwas Bill dilute enforcement of D&C Act? (NDTV, July 28, 2023)
Indian made cough syrup sent to Iraq contains poison, test show (Bloomberg, July 28, 2023)
Fake British cough syrup linked to Cameroon child deaths was made in India, officials say (The Telegraph, July 28, 2023)
India made cold syrup sent to Iraq tainted with toxic chemicals, shows test (Business Standard, July 28, 2023)
Indian cough syrup sent to Iraq contains poison, test show (The Mint, July 28, 2023)
Jan Vishwas Bill doesnt dilute punitive provisions of the Drugs and Cosmetics Act, says health ministry (The Print, July 28, 2023)
Sri Lanka stops buying eye drops made in Gujarat after infections, vision loss (Scroll.in, July 28, 2023)
Modi Govt likely to bring in stricter pan-India system to recall substandard drugs from the market (The Print, July 26, 2023)
Biosimilars need to be regulated better (Deccan Herald, July 26, 2023)
'Sue Indian Govt., Maiden Pharma, Importer in Cough Syrups case': Gambian Presidential Task Force (The Wire, July 23, 2023)
48 drug samples, including Alkem's PAN 40, Cadilla's ACILOC 50 fail to qualify CDSCO test (medicaldialogues.in, July 22, 2023)
India mustn't take shortcuts for making biosimilars, confusing affordability with efficacy is a bad idea (News18.com, July 17,2023)
Govt stops production of drugs at 31 firms over quality norms (Economic Times, July 13, 2023)
A WHO alert about an Indian pharma firm failed to spark strong regulatory action, experts say (Scroll.in, July 13, 2023)
Poisoned cough syrup killed kids. Authorities cut the investigation short (Bloomberg, July 11,2023)
Poisoned cough syrup traced to India reveals lapses in regulation (Business Standard, July 11, 2023)
Undercover Asia: Tainted Medicine Scandal (Undercover Asia, July 10, 2023)
Govt tightens screws on pharma MSMEs, stresses on good manufacturing practices, self regulation (The Print, 11 July 2023)
Drug quality concerns take center stage at pharma export council's global meet (Moneycontrol.com, July 08. 2023)
Make the drug approval files publicly accessible (Hindustan Times, July 7, 2023)
Tackling quality concerns in Indian drug exports (BQPrime, July 6, 2023)
'Probes bought bad name to Indian drug makers: RSS-affiliated MSME lobby writes to Health Ministry, then retracts ( News18, July 6, 2023)
Central drug authority to rationalize regulations (The Hindu, July 6, 2023)
Several immunizations drives hit, Union Govt prods Bharat Biotech over delays in vaccine supplies (The Print, July 6, 2023)
In search of consistent quality (Express Pharma, July 3, 2023)
Italian hospitals imported unapproved, substandard cancer drug (The Bureau of Investigative Journalism, June 29, 2023)
What is the truth behind made in India cough syrups which are linked to deaths of several children? (Lallantop, June 21, 2023)
"Made in India: medicines : How safe, how effective? (National Herald, June 20, 2023)
2 more Indian drug makers under lens in Nigeria for contamination (Business Standard, June 19, 2023)
More problems found at Indian pharma company causing cancer drug shortage (Bloomberg, June 15, 2023)
India probes bribery claim in toxic syrup case (Economic Times, June 13, 2023)
A WHO alert about an Indian pharma firm failed to spark strong regulatory action, experts say (Scroll.in, July 13, 2023)
India probes bribery claims in toxic syrup tests (Reuters, June 13, 2023)
Solan: No stern laws, fake drug makers misusing industrial plots (The Tribune, June 13, 2023)
India needs to restore faith in "World's Pharmacy" (Bloomberg, June 12, 2023)
India needs to restore faith in "World's Pharmacy" (Economic Times, June 12, 2023)
US military is so worried about drug safety, it wants to test widely used medicines (Bloomberg, June 7, 2023)
US FDA uncovers failures in Indian pharma factories (Deccan Herald, June 7, 2023)
Spare the rod, change the law (The Hindu, June 6, 2023)
Intas pharma Ahmedabad facility gets import alert from US FDA (Forbes India, June 5, 2023)
US watchdog cracks down on Indian drug makers (Bloomberg, June 5, 2023)
India bans 14 fixed dose medicines for likely posing risks to health (Economic Times, June 4, 2023)
The Gambia hires US lawyers over syrup scandal (BBC, June 2, 2023)
Is India doing enough to clean up its pharmaceutical industry (DW, June 02, 2023)
Gambia hires US law firm to consider action on toxic Indian cough syrups (Pharmalive, June 1, 2023)
Center probes Gujarat Pharma firm over its eyedrops being linked to vision damage cases in Sri Lanka (News18. June 1, 2023)
Contaminated drugs, shredded papers: US FDA uncovers Failures in Indian pharma factories (Bloomberg, May 31, 2023)
Lax fear on misleading traditional medicine advertisements, finger on Center (The Telegraph, May 27, 2023)
Indian drugs led to child deaths in The Gambia: Panel (Economic Times, May 24, 2023)
Global Experts' Causality Assessment confirms Indian cough syrups led to child deaths in the Gambia (The Wire, May 24, 2023)
We dont pay enough for drugs (Bloomberg, May 24, 2023)
Haryana blacklists Maiden Pharma, but no penal action (The Tribune, May 23, 2023)
Des médicaments indiens qui rendent malade (La Presse, May 21, 2023)
How India's drug regulatory regime can ensure greater credibility for our pharma industry (Indian Express, May 18, 2023)
India considers policy change after cough syrup deaths (Reuters, May 18, 2023)
Centre to come up with new drug export policy after concerns around quality (Business Standard, May 16, 2023)
The US needs to pressure India to improve drug safety (StatNews, May 16, 2023)
India's 'pharmacy of the world' moniker is under threat. Here's why (Forbes India, May 15, 2023)
India's evolving pharmaceutical industry needs stringent scrutiny (Greater Kashmir, May 11, 2023)
India's evolving pharmaceutical industry needs stringent scrutiny (Greater Kashmir, May 10, 2023)
Why are FDA inspections so ineffective and disappointing? (People's Pharmacy, May 8, 2023)
Why does India not have a law to recall bad quality drugs from the market (The Hindu, May 5, 2023)
Table talk with Jo: Indian pharma and its dangerous trail (YouTube, May 5, 2023)
Indian cough syrup: mystery middleman may be clue (Reuters, May 1, 2023)
Indian Cough Syrup: Mystery middleman maybe new clue (Reuters, April 29, 2023)
Sri Lanka suspends use of Indian eye drops (Newsfirst, April 20, 2023)
Book Review: How rotten is drug regulation in India? (HealthSense, April 17, 2023)
Of lies and misrepresentations in the EPW Book Review (dineshthakur.com, April 6, 2023)
India's drug industry needs a major overhaul (Economic Times, April 5, 2023)
Just how dangerous are India's generic drugs? Very (Washington Post, April 5,2023)
Just how dangerous are India's generic drugs? Very (BQ Prime, April 5, 2023)
Drug resistant bacteria tied to eye-drops can spread person to person (NY Times, April 3, 2023)
7 Baddi pharma units face "stop manufacturing" order after inspection (The Tribune, March 29, 2023)
"Spurious Drugs" Center cracks down on 18 firms (Hindustan Times, March 29, 2023)
Dont Dilute the Drugs and Cosmetics Act (Economic Times, March 29, 2023)
Licenses of 18 pharma firms cancelled in crackdown (Indian Express, March 29, 2023)
Govt cancels licenses of 18 pharma companies allegedly manufacturing spurious drugs (The Mint, March 29, 2023)
India's pharma sector has an export problem, here's where the challenges lie (BT Mag, April 2, 2023)
Low quality drugs are posing a risk to India's image. Can Rajeev Raghuvanshi fix the faults? (Economic Times, March 29, 2023)
Children are dying. We need a worldwide medicines treaty to avoid further tragedies (The Guardian, March 23, 2023)
WHO warns contaminated batches of Indian manufactured medication circulating in Lebanon and Yemen (The Telegraph, March 28, 2023)
FDA and WHO investigate contaminated cough syrup from India linked to 300 deaths (MDLinx, March 28, 2023)
Regulatory body cancels Marion Biotech's license (Hindustan Times, March 23, 2023)
PGI Propofol deaths: 6 months later, no one held responsible (Times of India, March 22, 2023)
Outbreak of extensively drug resistant pseudomonas aeruginosa associated with artificial tears (US CDC, March 21, 2023)
Explained: What is plaguing drug regulation in India? (Facts Cresendo, March 25, 2023)
Govt plans common drugs standards for all state drug regulators (Hindustan Times, March 17, 2023)
Editorial: Standardize Drug Regulation (Telangana Today, March 20, 2023)
Towards a more robust model of drug regulation (Hindustan Times Editorial, March 17, 2023)
Center should regulate manufacture of drugs instead of state bodies, new bill moots (Economic Times, March 12, 2023)
Doublespeak on Drug Regulation must stop (The Tribune, March 11, 2023)
Gambian child deaths fuel alarm over rules in "world's biggest pharmacy" India (Financial Times, March 11, 2023)
As African children died, doctors fought to get Indian cough syrup banned (Reuters, March 10, 2023)
The mystery of deadly poisoned cough syrup (The Telegraph, March 8, 2023)
Licenses of six cough syrup makers in Maharashtra suspended for violation of rules (The Hindu, March 4, 2023)
Book Review: Shocking study on drug regulation leaves us wiser (Deccan Chronicle, February 25, 2023)
The Bittersweet Pill (Medium, February 25, 2023)
The horror story of drug regulation in India (The Newsminute, February 20, 2023)
Regulating new drugs in India needs to be improved (The Lancet, February 17, 2023)
Contaminated cough syrups' death toll passes 300 in four months (Chemistry World, February 14, 2023)
Are medicines making our healthcare better or worse? (Newslaundry Hindi, February 14, 2023)
Ayurveda:Regulation of this alternate system of medicine is urgently needed on many fronts (DowntoEarth, February 14, 2023)
The contaminated syrup tragedy in Jammu and Kashmir's Ramnagar (Outlook India, February 12, 2023)
The Crisis of Drug Quality in India (Bangalore International Center, February 9, 2023)
Drug regulators in India must do better oversight (Deccan Chronicle, February 9. 2023)
Bharat Biotech's Krishna Ella suggests merging state drug regulators with the central body to ensure 'one quality one standard' (The Hindu, February 5, 2023)
Are Indian drugs safe? (IVM Podcasts, February 3, 2023)
Book review: How rotten is drug regulation in India? (BMJ Global Health, February 1, 2023)
Is Drug Regulation in India a myth? (The Diplomat, February 1, 2023)
Tainted drug deaths, weak regulation corrode confidence in Indian drugs (CIDRAP, January 28, 2023)
A strong dose (Frontline Magazine, January 26, 2023)
The drug was meant to save children's lives:Instead, they are dying (The Bureau of Investigative Journalism, January 25, 2023)
Inside India's shadowy pharma industry - dingy drug units, cash payments, poor inspections (The Print, January 24, 2023)
WHO investigating links between cough syrup deaths, considers advice to parents (Reuters, January 24, 2023)
WHO urges action to protect children from contaminated medicines (WHO, January 24, 2023)
WHO urges action after cough syrups linked to more than 300 child deaths (The Guardian, January 24, 2023)
The inaction of Indian drug regulators on cough syrup deaths (Economic Times, January 23, 2023)
Mind your medicine (The Telegraph, January 20, 2023)
Burn after reading: FDA blasts Intas for "cascade if failure" after investigations finds heaps of shredded documents (FiercePharma, January 20, 2023)
Inconsistent drug regulation spells danger for India's global pharma ambitions (BMJ, January 13, 2023)
Lethal Indian cough syrup strikes again (Splainer, January 13, 2023)
How did 70 Gambian and 19 Uzbek children die? (Herald Goa, January 13, 2023)
Cough syrup linked to 20 kids's deaths was circulating for months (Bloomberg, January 12, 2023)
Behind the Indian cough syrup that killed many in the Gambia and Uzbekistan (Frontline-Hindu, January 12, 2023)
WHO issues new warning on Indian cough syrup after 18 more child deaths (Washington Post, January 12, 2022)
India's lax oversight of pharmaceutical manufacturing imperils health around the world (STATNews, January 9, 2023)
From Whistleblower, Dinesh Thakur's long road to reforming India's pharmaceutical industry (ET Prime, January 9, 2023)
A scandal rocks India's pharmaceutical industry (The Economist, January 5, 2023)
The Truth about Drug Regulation in India (The India Forum, January 5, 2023)
Jailed for doing bad business: Why GOI should reconsider provisions of Jan Vishwas Bill that decriminalizes criminals (Economic Times, January 5, 2023)
Cough syrup deaths will still not wake Indian authorities (Times of India, January 2, 2023)
Cough syrup deaths: India must focus on systemic gaps over pharma reputation (The Quint, December 31, 2022)
Cough syrup deaths: India's drug regulator must stop treating public health crises as public relations problems (Indian Express, December 30, 2022)
Uzbekistan kids deaths bought 'Bad Name to India'- Firm's membership suspended (News18.com, December 30, 2022)
Indian pharma under scrutiny again after 18 Uzbek child deaths (Aljazeera, December 29, 2022)
Killer Syrup 2.0: Uzbekistan reports cough syrup deaths after Gambia (NDTV, December 29, 2022)
After Gambia, deaths of 18 children in Uzbekistan linked to India-made cough syrup (Mojo Story, December 29, 2022)
Bitter medicine for pharma regulation (Business Standard, December 28, 2022)
Uzbekistan says 18 children died due to cough syrup made by Indian firm Marion Biotech (Scroll.in, December 28, 2022)
Another Gambia type situation? Did 18 children did after consuming cough syrup made in India? (Firstpost, December 22, 2022)
10 unmissable books of 2022 on business, economics and finance (The Mint, December 28, 2022)
Only if the truth could come in a pill (Financial Express, December 18, 2022)
Delay in quality tests: Why Keralites consuming substandard medicine (Manorama Online, December 15, 2022)
Why India needs a national law to recall drugs (Mint Lounge, December 15, 2022)
Book Review: The Truth Pill (India Today, December 9, 2022)
"The Truth Pill": A lonely man's fight agains poorly regulated Indian pharmaceutical industry (Scroll.in, December 10, 2022)
Clearing the mess in India's Drug Regulatory System (All Things Policy, December 9, 2022)
Remedies for a broken system: Drug regulation in India (Artha Global, December 6, 2022)
Twitter spaces conversation on The Losing Battle to Regulate Traditional Medicine (December 2, 2022)
3 years on, no chargesheet in case of 12 kids' death in J&K (The Tribune, November 27, 2022)
82 kids had acute kidney injury, 70 died : Gambia (The Tribune, November 26, 2022)
Book Review: The Truth Pill - The Myth of Drug Regulation in India (Hindu Business Line, November 25, 2022)
Most countries do not forgive deaths of children (Rediff.com, November 22, 2022)
Book Review: The Truth Pill: Myth of Drug Regulation in India (Bill of Health, November 18, 2022)
'A very worrying scenario': Internal documents on India's Covid-19 vaccine raise troubling questions about approval process (STATNews, November 15, 2022)
'Unimaginable Shame': Narayana Murthy on Deaths due to Indian cough syrup (NDTV, November 15, 2022)
Know your author-Prashant Reddy (YouTube, November 12, 2022)
Review: The Truth Pill: The myth of drug regulation in India (Hindustan Times, November 12, 2022)
Mumbai's JJ Hospital to The Gambia: 36 years apart but familiar story of deadly toxic drugs (Scroll.in, November 11, 2022)
A Truth Pill in a Bottle of Lies (Moneylife, November 11, 2022)
Know your author-Simon and Schuster (YouTube, November 11, 2022)
Toxic cough syrup and poor quality control (ABC Australia, November 5, 2022)
Indian Drugs Are a Global Lifeline. For 70 Children, They Were Deadly (NY Times, November 3, 2022)
Banten Paracetamol Syrup producer uses chemical 100x safe limit (Jakarta Globe, November 1, 2022)
New drugs bill is wolf in sheep's clothing (The Probe India, October 31, 2022)
Cough medicine deaths highlight India's problem with substandard medicine (Health Policy Watch, October 31, 2022)
How safe are our drugs, with Dinesh Thakur (Indian Express, October 30, 2022)
After Gambian tragedy, Indonesia bans cough syrups (SciDev, October 28, 2022)
Tharoor Line: Indian drug firms need a heavy dose of quality check (Manorama Online, October 28, 2022)
Cough Syrup deaths: If media doesn't hold the government accountable, who will? (Newslaundry.com, October 27,2022)
Cough Syrup deaths: Why is India's drug regulator going after Dinesh Thakur and Prashant Reddy T (Newslaundry.com, October 26, 2022)
India's massive pharma industry hounded by scandals (DW, October 26, 2022)
Duo behind a 6 year long crusade to uncover loopholes in India's medicine manufacturing (The Better India, October 26, 2022)
What do we know about contaminated cough syrup linked to child deaths (TRT World, October 24, 2022)
33 years after deaths at JJ hospital due to adulterated glycerine, no lessons learnt (Times o India, October 24, 2022)
Gambia cough syrup deaths - adulterated medicines in India (The Lamppost, October 24, 2022)
Dinesh S Thakur and Prashant Reddy T's book "The Truth Pill' : Exposing underbelly of pharma business (The Tribune, October 24, 2022)
Unregulated, out of control: Drug Manufacturing in India (Deccan Herald, October 24, 2022)
Quá khứ tai tiếng của thuốc Ấn Độ: Từng có loại siro khác liên quan hàng loạt ca tử vong (Vietnam,net, October 23, 2022)
In de 'apotheek van de wereld" is de control gebrekkig (NRC, October 23, 2022)
India's pharma sector has much to answer (Hindustan Times, October 23, 2022)
CDSCO sends notice in the case of Gambian deaths related to cough syrup (Newslaundry, October 22, 2022)
Guest in the newsroom (Lallantop, October 22, 2022)
Here is what we know about the cough syrup scandal (NY Times, October 22, 2022)
Cough syrup deaths expose a lax drug regulation in India (The Lancet, October 22, 2022)
Can we trust India's drug regulator? Dinesh Thakur & Prashant Reddy weigh in (Forbes India, October 20, 2022)
Gambia children death case: What ails India's drug regulatory system (BQPrime, October 19, 2022)
CDSCO warns of legal action against Thakur & Reddy for failing to withdraw statements tarnishing CDSCO's image (Pharmabiz, October 19, 2022)
The role of the regulator is to protect the public, not pharma companies (Article-14, October 19, 2022)
Indian activists ask drug regulator to accept responsibility for Gambia child deaths (The Standard, October 18, 2022)
Contaminated cough syrup from India linked to 70 child deaths. Its happened before (NPR, October 18, 2022)
PM Modi's advice to prescribe Generic drugs could be dangerous because they are substandard (The Wire, October 18, 2022)
Jailed in Punjab, acquitted in Bengal - How judiciary handled drug law violations (The Print, October 18, 2022)
What ails our drug regulatory system (BQ Prime, October 18, 2022)
Suit threat against activist, lawyer for questioning CDSCO's role in Gambia deaths (The Telegraph, October 18, 2022)
India must act on drug adulteration-lives around the world are at stake (The Guardian, October 17, 2022)
India bashing WHO on cough syrup fiasco is old tale of pot calling the kettle black (News18, October 17, 2022)
Cough syrup deaths: Why drugs made in India are sparking safety concerns (BBC, October 17, 2022)
When Byculla was Gambia (Hindustan Times, October 17, 2022)
Feeding cough syrup seems like Russian Roulette (The Print, October 16. 2022)
Spurious drugs: Data shared not sufficient to reveal cause of illness, India writes to World Health Organization (Tribune India, October 16, 2022)
Launch of The Truth Pill (YouTube, October 15, 2022)
Contaminated cough syrup linked to 66 child deaths in Gambia (Chemistry World, October 14, 2022)
Answered: Six questions about cough syrup deaths linked to Haryana firm (The Mint, October 13, 2022)
Of drug quality, Gambia and India: an interview with the authors of The Truth Pill (The Hindu, October 13, 2022)
Deaths in Gambia must push us to fix drug regulation (The Mint, October 13, 2022)
Govt forms panel to probe WHO report on kids' death in Gambia (Times of India, October 13, 2022)
Gambia Cough Syrup Deaths: Are India-made drugs safe? Author of Truth Pill speaks (Moneycontrol.com. October 12, 2022)
Action against Haryana Pharma company: Dangerous cough syrup being sold in India? (NDTV, October 12, 2022)
India halts cough syrup production at factory after Gambia deaths (Al Jazeera, October 12, 2022)
Cough Syrup scandal: How did it end up in the Gambia (BBC, October 12, 2022)
Gambia: Grief, fear and anger over deadly cough syrup (AfricaNews, October 12, 2022)
Interview with Razia Iqbal on BBC Newshour about deaths of children in the Gambia (BBC, October 12, 2022, timestamp: 45 min)
Maiden Pharma skipped key testing in cough syrup: Notice (Hindustan Times, October 12, 2022)
Haryana Govt halts Maiden Pharma's production & issues show cause notice: Bad Medicine (CNBC TV18, October 12, 2022)
Podcast: Gambia cough syrup deaths- How safe are India made drugs (The Quint, October 11, 2022)
Maiden Pharma: Why should your license not be suspended/cancelled? asks CDSCO show cause notice (SouthFirst.com, October 11, 2022)
'Truth Pill': This book examines how some Indian drugs get away without meeting quality standards (Scroll.in, October 11, 2022)
Strengthen Drug Regulatory Framework (Hindustan Times, October 11, 2022)
Poisonous Prescriptions: The dark side of Indian pharma comes out with Africa's cough syrup deaths (The Economic Times, October 11, 2022)
Who is responsible for the deaths of 66 children in the Gambia (The Wire, October 11, 2022)
Multiple violations found during inspections at Sonepat drug firm (The Tribune, October 9, 2022)
India owes Africa a moral duty to ensure only high quality drugs are exported (Times of India, October 9, 2022)
Gambia Deaths: Pharma company issued show cause notice by Haryana authorities (Hindustan Times, October 9, 2022)
Cough Syrup row: "Habitual Offender" firm cleared to export drugs (India Today, October 8, 2022)
India's pharma industry's problems need to be fixed, now (Moneycontrol.com, October 8, 2022)
India needs a national drug recall law without further delay (Economic Times, October 8, 2022)
Four states in India find NSQ drugs made by Maiden Pharma (NDTV India, October 7, 2022)
The rise and rise of antibiotic use in India (Vice.com, October 7, 2022)
When cough syrup kills: How safe are India's drugs (Mojo Story, October 7, 2022)
Spurious Syrup: All five accused on bail, cops yet to file challan (Tribune India, October 7, 2022)
"Killer" cough syrup: Deadly lapses in Drug Laws: Left Right & Center (NDTV, October 6, 2022)
Book highlights burning issues on drug regulation in India (The Week, October 6, 2022)
Cough syrup deaths in the Gambia linked to an Indian manufacturer (The World, October 6, 2022)
Bad Medicine: Shereen Bhan in conversation with Dinesh Thakur and Prashant Reddy (CNBC TV 18, October 6, 2022)
A missed opportunity: New Drugs Bill is old medicine in new bottle (Deccan Herald, September 29,2022)
Doctor-Pharma nexus Part II: W`hat drives drug prescription in India (Moneycontrol.com,. September 23, 2022)
Bad Medicine: Fake history, post-colonial complicity: Ayurveda in the time of Covid (The Wire, Sept 16, 2021)
Some cures, some lingering ailments (Financial Express, September 8, 2022)
A missed opportunity to put drug regulations in place (The Leaflet, September 2, 2022)
The New Drugs Bill: A missed opportunity for reforms in Ayush (Business Standard; August 22, 2022)
Drugs, Medical Devices & Cosmetic Bill: Why the Bill is bad medicine (The Economic Times; August 19, 2022)
New drugs bill is a prescription for disaster (Indianexpress.com, August 9, 2022)
India’s drug approval system is broken but a proposed new law does nothing to fix it (scroll.in, August 06, 2022)
Drugs, medical devices & cosmetics bill 2022: A law whose date has expired (The Economic Times, July 24, 2022)
A new legislation that mirrors the old (The Hindu, July 20, 2022)
Opinion | India’s Ayush industry needs an entirely new regulatory model (Live Mint; July 08, 2020)
The many questions about Favipiravir (The Hindu; June 25, 2020)
State lethargy amidst cough syrup poisoning (The Hindu; Feb 29, 2020)
When violations aren’t penalised: The legality of the Patanjali advertising tsunami (Newslaundry; Feb 12, 2022)